Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Siolta Therapeutics

Request full access

Early stage, venture-backed biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases

San Carlos, United StatesFounded 2016Biotech & Life Sciences

About Siolta Therapeutics

Siolta Therapeutics is a clinical-stage biopharmaceutical company that develops live biotherapeutic products (LBPs) to prevent and treat diseases by modulating the human microbiome.

The company's platform integrates clinical data, bioinformatics, and microbial science to create precisely defined consortia of microbes. Siolta's primary focus is on the developing infant gut microbiome and its influence on immune system programming, a critical area for preventing allergic and inflammatory conditions.

By targeting the maternal-infant axis, Siolta aims to deliver therapeutic interventions that can establish a healthy microbiome from the earliest stages of life. The company's lead product, STMC-103, is a mixed-species LBP in clinical development for the prevention of atopic diseases such as eczema and asthma.

Siolta Therapeutics has secured substantial funding through Series B and C financing rounds, enabling the advancement of its clinical programs. The company also engages in strategic collaborations to further its research and development efforts.

Source: Dealroom company data

At a glance

Status
Operational
Employees
15
Open positions
None listed
Dealroom signal
73.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Mar 2024 $12M $150M Khosla Ventures · SymBiosis ↗
GRANT✓Other financing Feb 2022 — — US National Institute of Allergy and Infectious Diseases · National Institutes of Health ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Siolta Therapeutics website traffic

Latest recorded traffic for Siolta Therapeutics is 1.8K monthly website visits, up 20% over the last three months. Siolta Therapeutics's team grew 0% over the past year.

Latest monthly visits1.8K 3-month web change+20% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Siolta Therapeutics in the San Carlos ecosystem

Live from Dealroom

The Siolta Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Seventure Partners
  • Khosla Ventures
  • US National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Series A3 investors entered at this stage

Other known investors4 additional known investors

  • University of California, San Francisco
  • California Life Sciences
  • Kirin Health Innovation Fund
  • MBC Biolabs
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Siolta Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Siolta Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.